Nilutamide

Nilutamide

SCHEMBL5527279

CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O.NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AR

The experimentally established mechanism targets of Nilutamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR known ✓ P10275 12/20 0.69
MEN1 O00255 1/20 0.69
LMNA P02545 1/20 0.69
TP53 P04637 1/20 0.69
CYP1A2 P05177 1/20 0.69
PGR P06401 1/20 0.69
CYP3A4 P08684 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C9 P11712 1/20 0.69
TSHR P16473 1/20 0.69
ALOX12 P18054 1/20 0.69
NFKB1 P19838 1/20 0.69
CYP2C19 P33261 1/20 0.69
RAB9A P51151 1/20 0.69
KMT2A Q03164 1/20 0.69
PDE4D Q08499 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
NPSR1 Q6W5P4 1/20 0.69
GRM8 O00222 1/20 0.41
GRM6 O15303 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nilutamide SCHEMBL20695037 0.86 AR (0.89) ARMEN1LMNATP53CYP1A2
Nilutamide SCHEMBL12670 0.83 AR (1.00) ARMEN1LMNATP53CYP1A2
Nilutamide SCHEMBL29351021 0.83 AR (1.00) ARMEN1LMNATP53CYP1A2
Nilutamide SCHEMBL1462011 0.83 AR (1.00) ARMEN1LMNATP53CYP1A2
Nilutamide SCHEMBL5579273 0.82 AR (0.89) ARMEN1LMNATP53CYP1A2
Nilutamide SCHEMBL28562851 0.82 AR (0.98) ARMEN1LMNATP53CYP1A2
Nilutamide SCHEMBL115340 0.76 AR (0.73) ARMEN1LMNATP53CYP1A2
SCHEMBL10324758 0.75 AR (0.81) ARMEN1LMNATP53CYP1A2
SCHEMBL332500 0.74 AR (0.73) ARMEN1LMNATP53CYP1A2
SCHEMBL10554935 0.74 AR (0.73) ARMEN1LMNATP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1853539-A2 HONOKIOL DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Arbiser, Jack (US) 2007-11-14 EP disclosed
WO-2006107451-A2 HONOKIOL DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS UNIV EMORY (US) 2006-10-12 WO disclosed